COLISTIMIXIN PHEBRA colistimethate sodium 1million IU powder for nebuliser solution vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

colistimethate sodium, Quantity: 1 million IU

Mevcut itibaren:

Phebra Pty Ltd

INN (International Adı):

Colistimethate sodium

Farmasötik formu:

Inhalation

Kompozisyon:

Excipient Ingredients:

Uygulama yolu:

Inhalation

Paketteki üniteler:

30 vial

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Colistimixin Phebra powder for nebuliser solution is indicated for the treatment of colonisation and infections of the lung due to susceptible Pseudomonas aeruginosa in patients with cystic fibrosis. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Ürün özeti:

Visual Identification: White to off-white powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2014-04-02